Document is current
Any future updates will be listed below
-
Authors
Drosu, Natalia
Bjornevik, Kjetil https://orcid.org/0000-0002-2892-6986
Cortese, Marianna
Levy, Michael
Sollid, Ludvig M. https://orcid.org/0000-0001-8860-704X
- License Information
-
More Information
Article History
Accepted: 11 September 2024
First Online: 8 October 2024
Competing interests
: K.B. and M.C. have received funding from the European Commission under the Horizon Europe funding programme to conduct a clinical trial of tenofovir alafenamide for the treatment of multiple sclerosis (project number 101136991; ). All other authors declare no competing interests.
